Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Merima Sirbubalo has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quality by Design-Based Development of Solid Self-Emulsifying Drug Delivery System (SEDDS) as a Potential Carrier for Oral Delivery of Lysozyme

    by Merima Šahinović, Alharith Hassan, Katalin Kristó, Géza Regdon, Edina Vranić, Tamás Sovány

    For many years, researchers have been making efforts to find a manufacturing technique, as well as a drug delivery system, that will allow for oral delivery of biopharmaceuticals to their target site of action without impairing their biological activity. Due to the positive in vivo outcomes of this formulation strategy, self-emulsifying drug delivery systems (SEDDSs) have been intensively studied in the last few years as a way of overcoming the different challenges associated with the oral delivery of macromolecules. The purpose of the present study was to examine the possibility of developing solid SEDDSs as potential carriers for the oral delivery of lysozyme (LYS) using the Quality by Design (QbD) concept. LYS was successfully ion paired with anionic surfactant, sodium dodecyl sulphate (SDS), and this complex was incorporated into a previously developed and optimized liquid SEDDS formulation comprising medium-chain triglycerides, polysorbate 80, and PEG 400. The final formulation of a liquid SEDDS carrying the LYS:SDS complex showed satisfactory in vitro characteristics as well as self-emulsifying properties (droplet size: 13.02 nm, PDI: 0.245, and zeta potential: −4.85 mV). The obtained nanoemulsions were robust to dilution in the different media and highly stable after 7 days, with a minor increase in droplet size (13.84 nm) and constant negative zeta potential (−0.49 mV). An optimized liquid SEDDS loaded with the LYS:SDS complex was further solidified into powders by adsorption onto a chosen solid carrier, followed by direct compression into self-emulsifying tablets. Solid SEDDS formulations also exhibited acceptable in vitro characteristics, while LYS preserved its therapeutic activity in all phases of the development process. On the basis of the results gathered, loading the hydrophobic ion pairs of therapeutic proteins and peptides to solid SEDDS may serve as a potential method for delivering biopharmaceuticals orally.


  • Development of solid self-nanoemulsifying drug delivery systems (s-SNEDDS) for oral delivery of lysozyme

    by Merima Sirbubalo, Tamás Sovány, Katalin Kristó, Géza Regdon, Edina Vranić

  • Open Access

    3D Printing—A “Touch-Button” Approach to Manufacture Microneedles for Transdermal Drug Delivery

    by Merima Sirbubalo, Amina Tucak, Kenan Muhamedagic, Lamija Hindija, Ognjenka Rahić, Jasmina Hadžiabdić, Ahmet Cekic, Derzija Begic-Hajdarevic, Maida Cohodar Husic, Almir Dervišević, et al.

    Microneedles (MNs) represent the concept of attractive, minimally invasive puncture devices of micron-sized dimensions that penetrate the skin painlessly and thus facilitate the transdermal administration of a wide range of active substances. MNs have been manufactured by a variety of production technologies, from a range of materials, but most of these manufacturing methods are time-consuming and expensive for screening new designs and making any modifications. Additive manufacturing (AM) has become one of the most revolutionary tools in the pharmaceutical field, with its unique ability to manufacture personalized dosage forms and patient-specific medical devices such as MNs. This review aims to summarize various 3D printing technologies that can produce MNs from digital models in a single step, including a survey on their benefits and drawbacks. In addition, this paper highlights current research in the field of 3D printed MN-assisted transdermal drug delivery systems and analyzes parameters affecting the mechanical properties of 3D printed MNs. The current regulatory framework associated with 3D printed MNs as well as different methods for the analysis and evaluation of 3D printed MN properties are outlined.


  • Open Access

    COVID-19 challenges in organising teaching at a faculty of pharmacy

    by Ognjenka Rahić, Merima Sirbubalo, Amina Tucak, Jasmina Hadžiabdić, Alisa Elezović, Edina Vranić


  • Photopolymerization-Based Technologies for Microneedle Arrays Production

    by Merima Sirbubalo, Amina Tucak, Kenan Muhamedagić, Ognjenka Rahić, Ahmet Čekić, Edina Vranić


  • Improving the Formulation Aspects of Orodispersible Tablets by Co-processed Excipients: Results of the Latest Studies

    by Lamija Hindija, Jasmina Hadžiabdić, Amina Tucak, Merima Sirbubalo, Ognjenka Rahić

  • Transdermal Patches as Noninvasive Drug Delivery Systems

    by Jasmina Hadžiabdić, Lejla Šejto, Ognjenka Rahić, Amina Tucak, Lamija Hindija, Merima Sirbubalo


  • Open Access

    Neuartige Wirkstoffabgabesysteme für die Glaukomtherapie: Hürden und Lösungsansätze für die Formulierung

    by Ognjenka Rahić, Amina Tucak, Naida Omerović, Merima Sirbubalo, Lamija Hindija, Jasmina Hadžiabdić, Edina Vranić

    Das Glaukom gilt als eins der größten gesundheitlichen Probleme weltweit. Es ist die häufigste vermeidbare Erblindungsursache – zum Einen, weil es in der Frühphase asymptomatisch bleibt, zum Anderen wegen mangelnder Therapietreue der Patienten. Es gibt bei der Behandlung des Glaukoms verschiedene Herangehensweisen, die jeweils auf den Einzelfall abgestimmt werden müssen. Die erste Therapielinie ist eine medikamentöse Behandlung. Da jedoch die herkömmlichen Darreichungsformen zahlreiche Nachteile aufweisen, wird intensiv an der Entwicklung neuartiger Wirkstoffabgabesysteme für die Glaukomtherapie gearbeitet. Die vorliegende Übersichtsarbeit gibt einen Überblick über Lösungsansätze und Strategien bei der Entwicklung von Darreichungsformen wie in situ gelierenden Systemen, Nanosystemen, okulären Inserten, Kontaktlinsen, Cornea Shields aus Kollagen, okulären Implantaten, Mikronadeln und Iontophoresesystemen. Ergänzend werden Ergebnisse von Studien zur Wirksamkeit dieser Wirkstoffabgabesysteme kurz vorgestellt.

  • Open Access

    Optimization of Manufacturing Parameters of 3D Printed Solid Microneedles for Transdermal Drug Delivery

    by Kenan Muhamedagić, Amina Tucak, Merima Sirbubalo, Ognjenka Rahić, Lamija Hindija, Jasmina Hadžiabdić, Edina Vranić, Ahmet Čekić

    Microneedles (MNs) have been manufactured using a variety of methods from a range of materials, but most of them are expensive and time-consuming for screening new designs and making any modifications. Therefore, stereolithography (SLA) has emerged as a promising approach for MN fabrication due to its numerous advantages, including simplicity, low cost, and the ability to manufacture complex geometrical products at any time, including modifications to the original designs. This work aimed to print MNs using SLA technology and investigate the effects of post-printing curing conditions on the mechanical properties of 3D-printed MNs. Solid MNs were designed using CAD software and printed with grey resin (Formlabs, UK) using a Form 3 printer (Formlabs, UK). MNs dimensions were 1.2 × 0.4 × 0.05 mm, arranged in 6 rows and 6 columns on a 10 × 10 mm baseplate. MNs were then immersed in an isopropyl alcohol bath to remove unpolymerized resin residues and cured in a UV-A heated chamber (Formlabs, UK). In total, nine samples were taken for each combination of curing temperature (35, 50, and 70 °C) and curing time (5, 20, and 60 min). Fracture tests were conducted using a hardness apparatus TB24 (Erweka, Germany). MNs were placed on the moving probe of the machine and compressed until fracture. The optimization of the SLA process parameters for improving the strength of MNs was performed using the Taguchi method. The design of experiments was carried out based on the Taguchi L9 orthogonal array. Experimental results showed that the curing temperature has a significant influence on MN strength improvements. Improvement of the MN strength can be achieved by increasing the curing temperature and curing time.


  • Open Access

    Antihypertensives’ Rock around the Clock

    by Ognjenka Rahić, Amina Tucak, Merima Sirbubalo, Lamija Hindija, Jasmina Hadžiabdić

    Although homeostasis is a commonly accepted concept, there is incontrovertible evidence that biological processes and functions are variable and that variability occurs in cycles. In order to explain and understand dysregulation, which has not been embraced by homeostatic principles, the allostatic model has emerged as the first serious challenge to homeostasis, going beyond its homeostatic roots. Circadian rhythm is the predominant variation in the body, and it is a pattern according to which many physiological and pathological events occur. As there is strong experimental and clinical evidence that blood pressure fluctuations undergo circadian rhythm, there is equally strong evidence that targeted time therapy for hypertension provides a better outcome of the disease. The research has gone even further throughout the development and approval process for the use of pulsatile drug release systems, which can be considered as an option for an even more convenient dosage regimen of the medicines needed.